Chiasma Plunges 60% Following FDA Review, CEO 'Surprised, Disappointed And Respectfully Disagree With The Decision'
April 18, 2016 at 10:34 AM EDT
Shares of Chiasma Inc (NASDAQ: CHMA) plunged more than 60 percent Monday morning after the company provided an update regarding its ...
